Basic info
Industry
biotechnology research
Sectors
Biotechnology
Pharmaceutical
Small Molecules
STAT3
Cancer
Service Industry
Fibrosis
Inflammation
Health Care
Date founded
2017
Funding rounds raised
Total raised
$72M
from 2 investors over 2 rounds
T
Tvardi Therapeutics raised $72M on June 15, 2021
Investors: Slate Path Capital LP and Sporos Bioventures